Conexeu Sciences Inc. (CNXU)
NASDAQ: CNXU · Real-Time Price · USD
10.30
+0.06 (0.54%)
Jul 9, 2026, 1:46 PM EDT - Market open

Conexeu Sciences Income Statement

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Apr '26 Oct '25 Oct '24 Oct '23
Selling, General & Admin
6.913.670.410.04
Depreciation & Amortization Expenses
0.030.02--
Research & Development
0.330.270.24-
Total Operating Expenses
7.273.960.640.04
Operating Income
-7.28-3.96-0.64-0.04
Interest Income
0.10--
Interest Expense
0-0-0.02-
Other Non-Operating Income (Expense)
-0.020.040.190
Total Non-Operating Income (Expense)
0.080.040.170
Pretax Income
-7.2-3.92-0.47-0.04
Net Income
-7.2-3.92-0.47-0.04
Net Income to Common
-7.2-3.92-0.47-0.04
Shares Outstanding (Basic)
181372
Shares Outstanding (Diluted)
181372
Shares Change (YoY)
170.46%87.74%286.25%-
EPS (Basic)
-0.43-0.31-0.07-0.02
EPS (Diluted)
-0.43-0.31-0.07-0.02
Free Cash Flow
-4.38-1.69-0.23-0
Free Cash Flow Per Share
-0.24-0.13-0.03-0.00
EBITDA
-7.24-3.95-0.64-0.04
EBIT
-7.28-3.96-0.64-0.04
SEC Filings: 10-K · 10-Q